<DOC>
	<DOCNO>NCT01645709</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled , multi-center study evaluate safety , tolerability , efficacy Intra-Articular ( IA ) verapamil treatment joint pain patient knee osteoarthritis ( OA ) . Subjects discontinue analgesic medication entire duration study , except acetaminophen ( take need basis 2 g/day ) . At visit 2 , subject meet entry criterion randomize receive single injection IA verapamil IA placebo ratio 1:1 . Treatments give fluoroscopy ultrasound confirm needle placement . Subjects monitor blood pressure heart rate ( sit stand ) least 1 hour post-injection . Subjects evaluate week 1 , 2 , 3 , 4 , 6 , 8 , 12 treatment .</brief_summary>
	<brief_title>Safety , Tolerability , Efficacy IA Verapamil Treatment Joint Pain Subjects With Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Arthralgia</mesh_term>
	<mesh_term>Verapamil</mesh_term>
	<criteria>Subjects must meet follow inclusion criterion participate study : 1 . Be 3575 year age good general medical psychological health . 2 . Be able speak , read , write , understand English , understand consent form , complete studyrelated procedure , communicate study staff . 3 . Have OA least 1 knee ( target knee ) least 6 month meet follow criterion : OA document stand Xrays anteriorposterior patellafemoral view take within 1 month screen visit indicate KellgrenLawrence Grade 2 earlystage Grade 4 radiographic stage knee ; Have pain associate OA target knee least 25 last 30 day ; c. Meet American College Rheumatology clinical classification criterion , define pain target knee least 3 follow 6 item : Age &gt; 50 ; Morning stiffness &lt; 30 minute ; Crepitus active motion ; Bony tenderness ; Bony enlargement ; No palpable warmth synovium . 4 . Target knee type orthopedic and/or prosthetic device . 5 . Based standard physical examination target knee , neurovascular deficit , skin abnormality , meniscal abnormality , ligament instability . 6 . At treatment visit 2 prior randomization , score least 20 WOMAC pain subscale ( question 15 ) target knee inclinic average pain intensity score least 4/10 010 NRS 24hour recall . 7 . Be willing maintain present stable treatment modality ( e.g. , acupuncture physical therapy ) willing refrain initiate new treatment modality . 8 . Be willing stop take nonsteroidal antiinflammatory drug ( NSAIDs ) opioids duration study . 9 . If female childbearing potential ( ie , medically surgically sterilize postmenopausal 1 year ) fertile male sexual partner childbearing potential , willing use adequate reliable contraception throughout study ( eg , abstinence barrier additional spermicidal foam jelly , use intrauterine device hormonal contraception female subject partner male subject ) . 10 . Not enrolled clinical trial use investigational drug within 1 month . Subjects meet follow criterion eligible participate : 1 . Have KellgrenLawrence Grade 1 radiographic stage knee KellgrenLawrence Grade 4 radiographic end stage knee bone bone , ie , less 2 mm joint space . 2 . Be candidate knee replacement within next 6 month . 3 . Have body mass index &gt; 35 kg/m2 . 4 . Have Hospital Anxiety Depression Scale score &gt; 12 either subscale establish history major depressive disorder control medication . 5 . Have , Investigator 's opinion , clinically significant abnormality clinical laboratory test ( hematology , clinical lab , urinalysis ) . 6 . Have positive urine drug test illegal drug substance screen . 7 . Have , Investigator 's opinion , clinically significant abnormality electrocardiogram reading 8 . If female childbearing potential , positive pregnancy test screening . 9 . Have significant pain outside target knee , include significant hip back pain ( bilateral knee OA allow long target knee pain distinguish contralateral knee pain contralateral knee require treatment ) . 10 . Have pain affecting target knee due etiology OA . 11 . Have document history inflammatory arthritis , include rheumatoid arthritis . 12 . Have meniscal tear target knee . 13 . Have viscosupplementation hyaluronic acid product within 6 month prior screen . 14 . Have fail respond prior treatment viscosupplementation hyaluronic acid product . 15 . Have IA corticosteroid injection within 12 week intramuscular oral steroid within 4 week prior screen . 16 . Have surgery target knee within 6 month prior screen . 17 . Have use opioids 4 day per week past month prior screen . 18 . Are allergic , intolerant , acetaminophen . 19 . Have use verapamil within past 4 week allergic intolerant verapamil .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>